ID: ALA4177302
Chembl Id: CHEMBL4177302
PubChem CID: 145972002
Max Phase: Preclinical
Molecular Formula: C26H18ClN3O3
Molecular Weight: 455.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)Cn1c(Cc2ccc(Cl)cc2)nc2c(-c3ccccc3)nc3ccccc3c2c1=O
Standard InChI: InChI=1S/C26H18ClN3O3/c27-18-12-10-16(11-13-18)14-21-29-25-23(26(33)30(21)15-22(31)32)19-8-4-5-9-20(19)28-24(25)17-6-2-1-3-7-17/h1-13H,14-15H2,(H,31,32)
Standard InChI Key: YUKBYTSZEOGSDL-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 455.90 | Molecular Weight (Monoisotopic): 455.1037 | AlogP: 4.94 | #Rotatable Bonds: 5 |
| Polar Surface Area: 85.08 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 3.94 | CX Basic pKa: 3.26 | CX LogP: 4.61 | CX LogD: 1.85 |
| Aromatic Rings: 5 | Heavy Atoms: 33 | QED Weighted: 0.38 | Np Likeness Score: -0.91 |
| 1. Crespo I, Giménez-Dejoz J, Porté S, Cousido-Siah A, Mitschler A, Podjarny A, Pratsinis H, Kletsas D, Parés X, Ruiz FX, Metwally K, Farrés J.. (2018) Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase., 152 [PMID:29705708] [10.1016/j.ejmech.2018.04.015] |
Source(1):
